128 related articles for article (PubMed ID: 20184887)
21. Aminopyridine block of Kv1.1 potassium channels expressed in mammalian cells and Xenopus oocytes.
Castle NA; Fadous S; Logothetis DE; Wang GK
Mol Pharmacol; 1994 Jun; 45(6):1242-52. PubMed ID: 8022416
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of estrogen and progesterone on potassium channels expressed in Xenopus oocytes.
Wong CM; Tsang SY; Yao X; Chan FL; Huang Y
Steroids; 2008 Mar; 73(3):272-9. PubMed ID: 18068743
[TBL] [Abstract][Full Text] [Related]
23. High extracellular potassium ion concentration attenuates the blockade action of ketanserin on Kv1.3 channels expressed in xenopus oocytes.
Liang ZT; Wang XP; Zeng QT; Liao YH; Zou AR; Li L; Tu DN
Chin Med J (Engl); 2008 Dec; 121(24):2584-91. PubMed ID: 19187600
[TBL] [Abstract][Full Text] [Related]
24. Molecular determinants of KCNQ1 channel block by a benzodiazepine.
Seebohm G; Chen J; Strutz N; Culberson C; Lerche C; Sanguinetti MC
Mol Pharmacol; 2003 Jul; 64(1):70-7. PubMed ID: 12815162
[TBL] [Abstract][Full Text] [Related]
25. Potent suppression of Kv1.3 potassium channel and IL-2 secretion by diphenyl phosphine oxide-1 in human T cells.
Zhao N; Dong Q; Du LL; Fu XX; Du YM; Liao YH
PLoS One; 2013; 8(5):e64629. PubMed ID: 23717641
[TBL] [Abstract][Full Text] [Related]
26. Identification, synthesis, and activity of novel blockers of the voltage-gated potassium channel Kv1.5.
Peukert S; Brendel J; Pirard B; Brüggemann A; Below P; Kleemann HW; Hemmerle H; Schmidt W
J Med Chem; 2003 Feb; 46(4):486-98. PubMed ID: 12570371
[TBL] [Abstract][Full Text] [Related]
27. Distribution in rat brain of binding sites of kaliotoxin, a blocker of Kv1.1 and Kv1.3 alpha-subunits.
Mourre C; Chernova MN; Martin-Eauclaire MF; Bessone R; Jacquet G; Gola M; Alper SL; Crest M
J Pharmacol Exp Ther; 1999 Dec; 291(3):943-52. PubMed ID: 10565809
[TBL] [Abstract][Full Text] [Related]
28. Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels.
Gögelein H; Brendel J; Steinmeyer K; Strübing C; Picard N; Rampe D; Kopp K; Busch AE; Bleich M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Sep; 370(3):183-92. PubMed ID: 15340774
[TBL] [Abstract][Full Text] [Related]
29. Accessory Kvbeta1 subunits differentially modulate the functional expression of voltage-gated K+ channels in mouse ventricular myocytes.
Aimond F; Kwak SP; Rhodes KJ; Nerbonne JM
Circ Res; 2005 Mar; 96(4):451-8. PubMed ID: 15662035
[TBL] [Abstract][Full Text] [Related]
30. Acacetin causes a frequency- and use-dependent blockade of hKv1.5 channels by binding to the S6 domain.
Wu HJ; Wu W; Sun HY; Qin GW; Wang HB; Wang P; Yalamanchili HK; Wang J; Tse HF; Lau CP; Vanhoutte PM; Li GR
J Mol Cell Cardiol; 2011 Dec; 51(6):966-73. PubMed ID: 21906601
[TBL] [Abstract][Full Text] [Related]
31. New drugs targeting the cardiac ultra-rapid delayed-rectifier current (I Kur): rationale, pharmacology and evidence for potential therapeutic value.
Ford JW; Milnes JT
J Cardiovasc Pharmacol; 2008 Aug; 52(2):105-20. PubMed ID: 18670369
[TBL] [Abstract][Full Text] [Related]
32. Identification of Verapamil Binding Sites Within Human Kv1.5 Channel Using Mutagenesis and Docking Simulation.
Ding WG; Tano A; Mi X; Kojima A; Seto T; Matsuura H
Cell Physiol Biochem; 2019; 52(2):302-314. PubMed ID: 30816676
[TBL] [Abstract][Full Text] [Related]
33. Effects of diltiazem and nifedipine on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes.
Gao Z; Sun H; Chiu SW; Lau CP; Li GR
Br J Pharmacol; 2005 Feb; 144(4):595-604. PubMed ID: 15678082
[TBL] [Abstract][Full Text] [Related]
34. Kv1.5 is an important component of repolarizing K+ current in canine atrial myocytes.
Fedida D; Eldstrom J; Hesketh JC; Lamorgese M; Castel L; Steele DF; Van Wagoner DR
Circ Res; 2003 Oct; 93(8):744-51. PubMed ID: 14500335
[TBL] [Abstract][Full Text] [Related]
35. [Effects of telmisartan on voltage-gated Kv1.3 and Kv1.5 potassium channels expressed in Xenopus oocytes].
Li MW; Wang XP; Gao CY; Zou AR
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):165-8. PubMed ID: 19719998
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory actions of the phosphatidylinositol 3-kinase inhibitor LY294002 on the human Kv1.5 channel.
Wu J; Ding WG; Matsuura H; Tsuji K; Zang WJ; Horie M
Br J Pharmacol; 2009 Jan; 156(2):377-87. PubMed ID: 19154427
[TBL] [Abstract][Full Text] [Related]
37. Activation of voltage gated K⁺ channel Kv1.5 by β-catenin.
Munoz C; Tóvolli RH; Sopjani M; Alesutan I; Lam RS; Seebohm G; Föller M; Lang F
Biochem Biophys Res Commun; 2012 Jan; 417(2):692-6. PubMed ID: 22166221
[TBL] [Abstract][Full Text] [Related]
38. Block of hERG channel by ziprasidone: biophysical properties and molecular determinants.
Su Z; Chen J; Martin RL; McDermott JS; Cox BF; Gopalakrishnan M; Gintant GA
Biochem Pharmacol; 2006 Jan; 71(3):278-86. PubMed ID: 16325148
[TBL] [Abstract][Full Text] [Related]
39. Diphenyl phosphine oxide-1-sensitive K(+) channels contribute to the vascular tone and reactivity of resistance arteries from brain and skeletal muscle.
Fancher IS; Butcher JT; Brooks SD; Rottgen TS; Skaff PR; Frisbee JC; Dick GM
Microcirculation; 2015 May; 22(4):315-25. PubMed ID: 25808400
[TBL] [Abstract][Full Text] [Related]
40. Kv1.5 open channel block by the antiarrhythmic drug disopyramide: molecular determinants of block.
Aréchiga IA; Barrio-Echavarria GF; Rodríguez-Menchaca AA; Moreno-Galindo EG; Decher N; Tristani-Firouzi M; Sánchez-Chapula JA; Navarro-Polanco RA
J Pharmacol Sci; 2008 Sep; 108(1):49-55. PubMed ID: 18818480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
